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The parameters derived from reservoir-excess pressure analysis (RPA) have prognostic 
utility in several populations. However, evidence in type 2 diabetes (T2DM) remains scarce. 
We determined if these parameters were associated with T2DM, and whether they would 
predict cardiovascular events in individuals with T2DM. We studied 306 people with T2DM 
and cardiovascular disease (CVD) (DMCVD:70.4±7.8yrs), 348 people with T2DM but without 
CVD (DM:67.7±8.4yrs) and 178 people without T2DM or CVD (CTRL:67.2±8.9yrs). RPA-
derived parameters including reservoir pressure integral (INTPR), peak re ervoir pressure 
(MAXPR), excess pressure integral (INTXSP), systolic rate constant (SRC) and diastolic rate 
constant (DRC) were obtained by radial artery tonometry. INTPR was lower in DMCVD and 
DM than CTRL. MAXPR was lower, and INTXSP was greater in DMCVD than DM and CTRL. 
SRC was lower in a stepwise manner among groups (DMCVD<DM<CTRL). DRC was greater in 
DMCVD than CTRL. In the subgroup of individuals with T2DM (n=642), 14 deaths (6 
cardiovascular and 9 non-cardiovascular causes) and 108 cardiovascular events occurred 
during a 3-yr follow-up period. Logistic regression analysis revealed that INTPR [odds ratio 
0.59 (95%CI:0.45-0.79)] and DRC [odds ratio 1.60 (95%CI:1.25-2.06)] were independent 
predictors of cardiovascular events during follow-up after adjusting for conventional risk 
factors (both p<0.001). Further adjustments for potential confounders had no influence on 
associations. These findings demonstrate that altered RPA-derived parameters are 
associated with T2DM. Furthermore, baseline values of INTPR and DRC independently 
predict cardiovascular events in individuals with T2DM, indicating the potential clinical 
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Improved management of cardiovascular risk factors1 has led to a significant reduction in 
cardiovascular incidence in type 2 diabetes (T2DM), but cardiovascular disease (CVD) 
remains the leading cause of morbidity and mortality in individuals with T2DM.2 The 
prevalence of T2DM has doubled during the past 20 years and CVD in people with T2DM is 
likely to cause a significant burden on the health care system in the near future.3 Therefore, 
an improvement in CVD risk prediction in those with T2DM is essential. 
 
Alterations in macro- as well as microvasculature are evident in T2DM,4, 5 and thus altered 
central hemodynamics could play an important role in the development of CVD in this 
condition. It has been suggested that central blood pressure (BP) and its morphological 
parameters may provide prognostic information on cardiovascular risks and subsequent 
cardiovascular events beyond those obtained from brachial artery BP alone.6 Indeed, central 
BP is closely associated with subclinical biomarkers of cardiovascular risk such as carotid 
intima-media thickness (CIMT) and left ventricular mass (LVM),6 and the reduction in CIMT 
and regression of LVM are more closely associated with the reductions in central pulse 
pressure (PP) than brachial PP.7, 8 However, the evidence to support the proposition that 
central BP and its morphological parameters may provide better prognostication on future 
cardiovascular events has been equivocal in a hypertensive population and the general 
population.9, 10 This is particularly relevant in T2DM because, although brachial PP has 
previously been shown to predict cardiovascular events in T2DM,11-13 the prognostic utility 
of central BP and its morphological parameters is unclear in this context. Furthermore, 
augmentation index, a proxy for wave reflection that is commonly used as a morphological 






















    
    
    
    
    













issues may point to a need for an alternative approach that could be utilised for the 
refinement of CVD risk prediction in individuals with T2DM. 
 
Reservoir-excess pressure analysis is an approach to conceptualise components of conduit 
artery pressure waveform. In this analysis, the measured pressure waveform can be 
considered to have two components: the reservoir pressure component that reflects the 
theoretical minimum hydraulic work required to generate a given stroke volume; and the 
excess pressure component provides an index of unnecessary work done by the ventricle in 
each cardiac cycle.16 Both components are related to wave phenomena.17 The prognostic 
utility of the parameters derived from reservoir-excess pressure analysis has been 
demonstrated in several different populations, including patients with hypertension,18, 19 
suspected coronary artery disease,20 end-stage renal disease,21, 22 heart failure23 and in the 
general population.24 However, the utility of these parameters in T2DM is limited25, 26 and 
their prognostic utility in the population remains unknown.  
 
Therefore, we aimed to determine the prognostic utility of reservoir-excess pressure 
parameters in T2DM. We first determined whether these parameters were associated with 
T2DM, and subsequently determined whether the reservoir-excess pressure parameters 
would independently predict cardiovascular events in this population. Conventionally 
obtained central and peripheral artery hemodynamic parameters were also included in 
these analyses alongside the reservoir-excess pressure parameters to compare the 
























    
    
    
    
    













The data that support the findings of this study are available from the corresponding author 
upon reasonable request. 
 
Participants 
This is an ancillary study of the SUrrogate markers for Micro- and Macro-vascular hard 
endpoints for Innovative diabetes Tools-Vascular Imaging Prediction (SUMMIT-VIP) study.  
Participants were 832 individuals recruited for the SUMMIT-VIP study from Exeter, Dundee 
(both United Kingdom) and Malmö (Sweden) sites. Of those, 306 had T2DM and CVD 
(DMCVD: 70.4±7.8yrs, 94F), 348 had T2DM without CVD (DM: 67.7±8.4yrs, 142F) and 178 
had neither T2DM nor CVD (CTRL: 67.2±8.9yrs, 83F). A detailed description of the SUMMIT-
VIP study, including inclusion/exclusion criteria, has been described elsewhere,4, 27 and 
summarised in the Supplemental Material. UK National Research Ethics Service South West 
Committee, East of Scotland Research Ethics Service and the Institutional Ethics Committee 
at the University of Lund approved all study procedures, and written informed consent was 
obtained from all participants.  
 
Acquisition of radial pressure waveforms and derivation of conventional central artery 
hemodynamic parameters 
Applanation tonometry of the radial artery was performed using a SphygmoCor system 
(AtCor Medical Pty Ltd, West Ryde, Australia). Participants lay supine on an examination bed 
and rested for 10 min before assessment. Right radial artery pressure waveforms were 
recorded over 10 seconds with a high-fidelity micromanometer (SPT-304, Millar Instrument, 
Houston, TX) attached to the SphygmoCor system. Waveforms were then processed 






















    
    
    
    
    













radial pressure waveform calibrated by brachial systolic and diastolic pressures (as per the 
manufacturer’s suggestion), and a corresponding aortic pressure waveform was derived 
using a previously validated generalised transfer function.28, 29 The following central artery 
hemodynamic parameters were obtained for analysis in this study: central systolic and 
diastolic BP, central PP, central augmented pressure (AP), central augmentation index 
adjusted for a heart rate of 75 beats per min. Three separate waveform data were acquired 
for each participant and the average of these acquisitions was used as representative for 
statistical analysis.  
 
A supine brachial BP was measured three times at 1-min intervals using validated semi-
automated oscillometric devices (Omron M6, Hoofddorp, Netherlands). The average of the 
last two measurements was used as a representative brachial systolic pressure, diastolic 
pressure and PP.   
 
Calculation of reservoir-excess pressure parameters 
Reservoir-excess pressure parameters were calculated based on a pressure-alone approach 
from the ensemble averaged radial pressure waveforms without the application of a 
generalized transfer function. In the reservoir-excess pressure analysis,17 the measured 
pressure waveform can be separated into 1) a reservoir pressure component which varies in 
magnitude through changes in the resistance to outflow from the reservoir, the reservoir 
compliance and the asymptotic pressure,30 and 2) an excess pressure component which is 
the difference between the measured pressure waveform and reservoir pressure. The 
calculation of the reservoir pressure depends on determination of two rate constants: the 






















    
    
    
    
    













proportionality between the excess pressure and the arterial inflow and the total arterial 
compliance; and the diastolic rate constant (DRC) which is the inverse of the product of the 
peripheral vascular resistance and the total arterial compliance. Figure 1 shows a schematic 
example of the reservoir-excess pressure separation. A review of the method including its 
theoretical basis and validation has been published recently.17 The following reservoir-
excess pressure parameters were obtained for analysis in this study: reservoir pressure 
integral (INTPR), peak reservoir pressure (MAXPR), excess pressure integral (INTXSP), SRC 
and DRC.                     
                                          
Follow-up 
The participants with T2DM irrespective of the CVD status at baseline (n=654) were 
followed-up for a period of 3 years. Of those, 12 participants were excluded from the final 
analysis (n=642) due to the missing data that were used to adjust for multivariate logistic 
regression analysis (Supplemental Figure S1). Clinical events that occurred during this 
period were recorded as defined in the SUMMIT-VIP study.27 These included cardiovascular 
mortality, myocardial infarction, unstable angina, cardiac arrest, revascularization 
procedures, peripheral arterial disease, cerebrovascular events (stroke and transient 
ischaemic attacks) and non-cardiovascular mortality.    
 
Statistical analysis 
Data are presented as means±SD, means [95% confidence intervals (CI)] or number (%). 
Skewed data were log-transformed for statistical analysis. A Chi-square test was used to 
compare categorical parameters between groups. An analysis of (co)variance 






















    
    
    
    
    













comparisons of continuous data (after adjusting for age and sex for variables other than age 
and sex). Due to the unavailability of time-to composite cardiovascular event data, 
univariate and multivariate logistic regression analyses were used to determine associations 
between baseline values of reservoir-excess pressure parameters, and conventional central 
and peripheral artery hemodynamic parameters and incident cardiovascular events during 
the 3-year follow-up period in individuals with T2DM, and reported as odds ratio (OR) with 
95% CI. Reservoir-excess pressure parameters, and conventional central and peripheral 
artery hemodynamic parameters were standardised before entering into the logistic 
regression analysis to allow comparisons across the parameters. Covariates were chosen a 
priori as being established risk factors for CVD and complete case analysis was performed as 
levels of missingness were minimal (<10%). All statistical analysis was conducted using IBM 
SPSS Statistics 25 (IBM, Armonk, NY) and statistical significance was set at p<0.05.  
 
RESULTS: 
Baseline characteristics of the study participants 
Characteristics of the study participants are presented in Table 1.  
 
Reservoir-excess pressure parameters, and conventional central and peripheral artery 
hemodynamic parameters between groups 
Reservoir-excess pressure parameters stratified by group are presented in Figure 2. INTPR 
was lower in DMCVD [85.8 (83.9-87.6) mmHg∙s] and DM [87.7 (86.0-89.4) mmHg∙s] than 
CTRL [95.9 (93.5-98.3) mmHg∙s]. MAXPR was lower in DMCVD [104.6 (103.0-106.2) mmHg] 
compared to DM and CTRL [107.9 (106.5-109.4) mmHg and 109.8 (107.7-111.8) mmHg, 






















    
    
    
    
    













CTRL [7.0 (6.8-7.2) mmHg∙s and 6.7 (6.4-7.0) mmHg∙s, respectively]. SRC was lower in a step-
wise manner among the groups [DMCVD: 6.4 (6.2-6.6) 1/s, DM: 7.0 (6.8-7.3) 1/s, CTRL: 7.6 
(7.3-7.9) 1/s). DRC was greater in DMCVD [2.4 (2.3-2.5) 1/s] than CTRL [2.2 (2.1-2.3) 1/s], but 
was similar between DMCVD and DM [2.3 (2.3-2.4) 1/s]. 
 
Conventional central and peripheral artery hemodynamic parameters stratified by group are 
also presented in Table 1. Central diastolic BP was lower and central PP was higher in 
DMCVD compared with DM and CTRL. DM showed a trend for lower central AP compared 
with DMCVD and CTRL. Brachial PP was higher in DMCVD and DM compared with CTRL. 
Other parameters were similar between the groups.     
 
Incidence of cardiovascular event during the 3-year follow-up period in type 2 diabetes  
In the subgroup of individuals with T2DM (n=642), 14 deaths (6 cardiovascular and 9 non-
cardiovascular causes) and 108 composite cardiovascular events occurred during a 3-year 
follow-up period (see Supplemental Table S1 for the breakdown of cardiovascular events 
that occurred). Table 2 shows selected baseline characteristics of individuals with T2DM 
stratified by the incidence of cardiovascular event during the 3-year follow-up period. In 
those who had a cardiovascular event during the follow-up period, HbA1c level was higher 
and heart rate was faster than in those who had no event. In the group that had had a 
cardiovascular event during the follow-up period, smoking, a previous history of CVD and 
insulin treatment were more prevalent than in the other group. Other parameters were 























    
    
    
    
    













Reservoir-excess pressure parameters of individuals with T2DM stratified by the incidence 
of cardiovascular event during the 3-year follow-up period are presented in Table 2. At 
baseline, INTPR was lower, and DRC was greater in those with cardiovascular events than 
those without. INTXSP tended to be greater in those with cardiovascular events than in 
those without. 
 
Conventional central and peripheral artery hemodynamic parameters of individuals with 
T2DM stratified by the incidence of cardiovascular event during the 3-year follow-up period 
is also presented in Table 2. Brachial PP was higher in those with cardiovascular events than 
in those without. Central PP tended to be higher in those with cardiovascular events during 
the follow-up period than in those without. Other parameters were similar between the 
groups. 
 
Logistic regression analysis was performed to determine whether reservoir-excess pressure 
parameters, and central and peripheral artery hemodynamic parameters would 
independently predict the incidence of cardiovascular events during the 3-year follow-up 
period in individuals with T2DM. In a minimally adjusted (age and sex) logistic regression 
model (Figure 3A), INTPR (OR: 0.699, 95% CI: 0.545-0.897, p=0.005), INTXSP (OR: 1.238, 95% 
CI: 1.011-1.628, p=0.041), and DRC (OR: 1.499, 95% CI: 1.217-1.846, p<0.001) were 
significant independent predictors of the incidence of cardiovascular events during the 
follow-up period. In addition, in the same minimally adjusted logistic regression model 
(Figure 3B), central PP (OR: 1.281, 95% CI: 1.001-1.640, p=0.049) and brachial PP (OR; 1.332, 
95% CI: 1.042-1.703, p=0.022) were significant independent predictors of the incidence of 






















    
    
    
    
    














In a multivariate logistic regression model after adjusting for age, sex, total and HDL 
cholesterol, current smoking, systolic BP, pharmacological hypertensive treatment and 
study centre (Figure 3C), INTPR (OR: 0.594, 95%CI: 0.446-0.792, p<0.001) and DRC (OR: 
1.602, 95%CI: 1.246-2.059, p<0.001) independently predicted the incidence of 
cardiovascular events during the follow-up period. In the same logistic regression model 
(Figure 3D), however, none of the conventional central and peripheral artery hemodynamic 
parameters independently predicted the incidence of cardiovascular events during the 
follow-up period. These observations remained unaltered after further adjustments for 
body mass index, resting heart rate, haemoglobin A1c, previ us history of cardiovascular 
disease, estimated glomerular filtration rate, duration of T2DM and insulin treatment (Table 
3 and Supplemental Figure S2-S4). 
 
When INTPR and DRC were forced into the same multivariate logistic regression model 
together with age, sex, total and HDL cholesterols, current smoking, systolic BP, 
pharmacological hypertensive treatment and study centre, odds ratio were negligibly 
altered, and INTPR (OR: 0.642, 95% CI: 0.464-0.888, p=0.007) and DRC (OR: 1.434, 95% CI: 
1.101-1.870, p=0.008) independently predicted the incidence of cardiovascular events 
during the follow-up period. The strength of these associations were essentially unaltered 
by further adjustments for body mass index, resting heart rate, haemoglobin A1c, previous 
history of cardiovascular disease, estimated glomerular filtration rate, duration of T2DM and 
insulin treatment [INTPR (OR: 0.566, 95% CI: 0.319-1.005, p=0.052) and DRC (OR: 1.397, 95% 
CI: 1.060-1.840, p=0.018)], although the 95% confidence intervals of the estimates were 






















    
    
    
    
    













                                        
DISCUSSION: 
Each of the reservoir-excess pressure parameters explored in this study demonstrate a 
different association with T2DM and/or CVD. Furthermore, reservoir-excess pressure 
parameters, namely DRC and INTPR, independently predicted the incidence of 
cardiovascular events during the 3-year follow-up period in individuals with T2DM. This is 
the first study, to the best of our knowledge, to demonstrate the potential utility of 
reservoir-excess pressure parameters for cardiovascular risk stratification in individuals with 
T2DM. 
 
Reservoir-excess pressure parameters are associated with type 2 diabetes and 
cardiovascular disease at baseline 
Each reservoir-excess pressure parameter studied at baseline in this study has a different 
association with T2DM and the presence of CVD: INTPR was lower in T2DM than in CTRL 
irrespective of the presence of CVD. MAXPR was lower and INTXSP was greater in DMCVD 
compared with DM and CTRL. Interestingly, SRC and DRC exhibited stepwise alterations 
among DMCVD, DM and CTRL. From these observations, the information contained in the 
pressure waveform of the individuals with T2DM can be explained as follows. First, the 
lower INTPR in T2DM compared with CTRL indicates that a buffering capacity of central 
arteries, especially the aorta, is attenuated in T2DM due to stiffened central arteries, and 
this decline in the buffering capacity will result in a smaller proportion of stroke volume 
stored in systole and a faster discharge of blood from the aorta in diastole (consistent with 
the higher DRC). The proportionate increase in INTXSP compared with MAXPR in DMCVD 






















    
    
    
    
    













an index of circulatory dysfunction.16 Indeed, the association of INTXSP with subclinical 
biomarkers of target organ damage18 and the prognostic utility of INTXSP has been 
demonstrated in several cohorts although not previously in people with diabetes.18, 21-23 
Finally, the stepwise alterations in SRC and DRC with increasing cardiovascular risk (cf. DM 
vs DM and CVD) is indicative of how the rate of reservoir filling and emptying linked to 
central artery stiffness may influence different aspects of the ventricular-vascular 
interaction. These alterations in SRC and DRC provide insight into the accumulation of 
cardiovascular risk and may have a utility for cardiovascular risk stratification in T2DM. The 
potential utility of SRC for risk stratification has been demonstrated in people with 
hypertension19 and the general population,24 and an association between DRC and kidney 
function has been reported.31 Taken together with our observations that DRC and INTPR 
independently predicted the incidence of cardio ascular events over three years in T2DM, it 
is likely that the parameters derived from the diastolic phase, i.e. DRC and INTPR, may be 
more clinically relevant parameters than those derived from the systolic phase, at least in 
T2DM. 
 
Reservoir pressure integral and diastolic rate constant predict cardiovascular events in 
type 2 diabetes 
DRC and INTPR were both predictors of cardiovascular events in T2DM during the 3-year 
follow-up period, independent of conventional cardiovascular risk factors, and the 
prognostic ability of these parameters remained unaltered even after both parameters were 
forced into the same multivariate logistic regression model. These observations indicate 
that each parameter might possess unique prognostic information on the incidence of 






















    
    
    
    
    














Diastolic rate constant      
DRC in our T2DM population was associated with >60% increased odds of future 
cardiovascular events. DRC measures the rate of reservoir emptying during diastole, and 
with reference to a simple Windkessel model, can be interpreted as the inverse of the 
product of peripheral vascular resistance and total arterial compliance. Accordingly, it is 
challenging to separate individual contributions of each parameter to explain the greater 
DRC observed in those who experienced cardiovascular events in this study. However, 
because a greater central artery stiffness (i.e. a reduced arterial compliance) is a well-known 
observation in T2DM,4 it is plausible that the reduced total arterial compliance may account 
for the greater DRC, and the observed association between DRC and increased 
cardiovascular events in T2DM.  
 
A primary role of central arteries, especially of the aorta, is to accommodate and buffer the 
intermittent blood flow ejected from the left ventricle by expanding its calibre during 
systole so that an outflow continues by recoiling during diastole.32 This buffering function 
becomes less effective with central arteries stiffening, resulting in a greater DRC. Therefore, 
the greater DRC may indicate a deleterious influence of central artery stiffness on highly 
perfused organs such as the brain, heart and kidneys, by increasing the penetration of 
excessive pulsatile energy into the microcirculation,33 and also by reducing the amount of 
perfusion during diastole. The latter may be especially harmful for the heart since the 
majority of coronary artery perfusion occurs in diastole, potentially leading to 























    
    
    
    
    













Contrary to our null finding, SRC has been demonstrated to independently predict 
cardiovascular events in an elderly hypertensive population.19 The authors suggested that 
lower values of central artery stiffness and aortic characteristic impedance may account for 
a faster rate of reservoir filling and hence the protective effect of higher SRC in the elderly 
hypertensives. There are some methodological differences that could explain the divergent 
results between the studies, for example, use of carotid vs radial pressure waveforms. 
Alternatively, the discrepancies between the studies might imply differences in the 
importance of the systolic phase of ventricular-vascular interaction in hypertension and 
T2DM. Although this latter suggestion should be seen as speculative, the parameters 
describing the time-course of reservoir pressure changes (SRC and DRC) may provide more 
clinical utility than the conventional pulse waveform morphological parameters, such as 
augmentation index which did not differ markedly between groups in our study and failed 
to predict future events. 
 
Reservoir pressure integral 
The reservoir pressure represents the theoretical minimum hydraulic work required to 
generate a given stroke volume,16 and has a physiological foundation as corresponding to 
the instantaneous volume of blood stored in an artery.35 In this study, INTPR demonstrated 
an association with future cardiovascular events in our T2DM cohort and, compared to DRC, 
the association with cardiovascular events was negative, indicating that a higher INTPR is 
protective rather than detrimental for the incidence of cardiovascular events. This 
observation seems somewhat at odds with the well-established view that high BP increases 
cardiovascular morbidity and mortality,36 and a previous investigation has also 






















    
    
    
    
    













cardiovascular events in patients undergoing coronary angiography for suspected coronary 
artery disease.20 Comparing our follow-up cohort at baseline (Table 2), INTPR was 
significantly smaller in those who experienced the cardiovascular events than those who did 
not, whereas MAXPR was similar between them. Furthermore, DRC was significantly greater 
in those who experienced the cardiovascular events than those who did not, whereas SRC 
was similar between them. Taken together with the notion that the reservoir pressure 
component makes a major contribution to the diastolic phase of the pressure waveform,16 it 
is likely that the same mechanism responsible for the greater DRC may explain the smaller 
INTPR – that is, the increased central artery stiffness diminishes the buffering capacity of 
central arteries. It could also be plausible that the diminished buffering capacity may cause a 
smaller blood volume that can be stored in systole, although the effect of this will probably 
be marginal given the similarities in MAXPR and SRC observed between our groups. The 
smaller blood volume stored in central arteries in systole could in turn be discharged faster 
in diastole by the faster recoiling, potentially leading to a vicious cycle of diminished 
reservoir function and increasing cardiovascular risks in individuals with T2DM.   
 
Conventional central and peripheral hemodynamic parameters did not predict the 
incidence of cardiovascular events in type 2 diabetes 
In the minimally (age and sex) adjusted logistic regression model, both central and brachial 
PP were significantly associated with the incidence of cardiovascular events during the 3-
year follow-up period. However, neither parameter was associated with the incidence of 
cardiovascular events after adjusting for conventional risk factors and study centre; and this 
was unaffected by further adjustment for other potential cofounders. Compared to these 






















    
    
    
    
    













for cardiovascular events in T2DM.11-13 The reason for these divergent results is unclear, but 
could relate to well-controlled BP with pharmacological treatment in our T2DM participants. 
Nevertheless, given the prognostic utility of reservoir-excess pressure parameters along 
with the lack of prognostic utility with conventional central and peripheral hemodynamic 
parameters demonstrated in this study, these observations clearly suggest that the 
conventionally obtained central and peripheral artery hemodynamic parameters may not be 
capable of capturing clinical information from the pressure waveform sufficient to provide 
prognostic utility in T2DM. The lack of prognostic utility of conventional parameters 
analysed in this study could arise from the fact that they are derived either from extreme 
points on the pressure waveform (e.g. systolic and diastolic BP) or from derivatives 
calculated from specific points on the waveform (e.g. PP and AIx), rather than extracting 
information from the waveform morphology as a whole (e.g. DRC and INTPR). Conversely, 
the waveform analysis, such as reservoir-excess pressure analysis, could be useful in people 
with T2DM, even in those whose BP is well-controlled, as it may identify more subtle 
hemodynamic abnormalities.  
 
Limitations 
Data on left ventricular function by echocardiography are not available in this study. 
Because the systolic phase of ventricular-vascular interaction and hence INTXSP and SRC 
may be dependent on myocardial contractility and stroke volume, our findings should be 
interpreted in this context. Additionally, the data on peripheral vascular resistance are not 
available. However, the majority of our follow-up T2DM participants were taking 
vasodilating antihypertensive medications, and accordingly the inter-participant variability 






















    
    
    
    
    













shifted further toward central artery stiffness in our cohort and thus we think that our 
interpretation of the results is plausible. Lack of time to event data for the composite 
cardiovascular outcome meant that the evaluation of prognostic significance had to be 
performed by logistic regression analysis rather than survival analysis; however, given the 
low proportion of events, the loss of efficiency due to the use of logistic regression would be 
expected to have been very small.37 Finally, all participants who were followed-up over 
three years were older people with T2DM. Therefore, the findings may not be applicable to 
other populations.    
 
Perspectives  
We demonstrate that each reservoir-excess pressure parameter has a different association 
with T2DM and/or CVD. Furthermore, we present evidence that reservoir-excess pressure 
parameters independently predict the incidence of cardiovascular events during the 3-year 
follow-up period in individuals with T2DM. Conversely, conventional central and peripheral 
artery hemodynamic parameters did not demonstrate the prognostic utility in the same 
cohort. These results support the concept that the conduit artery pressure waveform 
contains clinically meaningful information for cardiovascular risk stratification, and also 
suggest that reservoir-excess pressure analysis may provide an additional tool for 
cardiovascular risk stratification in individuals with T2DM, over and above conventional 
interpretation of pressure waveform.   
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NOVELTY AND SIGNIFICANCE: 
What Is New?  
 The parameters derived from reservoir-excess pressure analysis, namely reservoir 
pressure integral and diastolic rate constant, independently predict the incidence of 
cardiovascular events in people with type 2 diabetes (T2DM), whereas conventional 
central and peripheral hemodynamic parameters do not in the same cohort.  
 Additionally, each reservoir-excess pressure parameter has a different association 
with the presence of T2DM and/or cardiovascular disease. 
What Is Relevant? 
 The prognostic utility of conventional central blood pressure and its morphological 
parameters is unclear in people with T2DM. 
 Reservoir-excess pressure analysis may provide useful information on cardiovascular 
risk stratification in people with T2DM that is not available from the conventional 
interpretation of blood pressure waveform. 
Summary 
 Reservoir-excess pressure parameters indicate disturbed cardiovascular function and 
























    
    
    
    
    













Figure 1. A schematic representation of reservoir-excess pressure separation in the radial 
artery. INTPR, reservoir pressure integral; MAXPR, peak reservoir pressure; INTXSP, excess 
pressure integral; SRC, systolic rate constant; DRC, diastolic rate constant. Adapted from 
Davies et al.18 
Figure 2. Comparisons of reservoir-excess pressure parameters among the groups at 
baseline. The data are shown as medians (95% confidence intervals). DMCVD, type 2 
diabetes with cardiovascular disease group; DM, type 2 diabetes group; CTRL, control group; 
INTPR, reservoir pressure integral; MAXPR, peak reservoir pressure; INTXSP, excess pressure 
integral; SRC, systolic rate constant; DRC, diastolic rate constant. 
Figure 3.  Logistic regression analysis of reservoir-excess pressure parameters, and 
conventional central and peripheral artery hemodynamic parameters for predicting 
cardiovascular events in individuals with type 2 diabetes. A: Results of a minimally adjusted 
(age and sex) logistic regression analysis of reservoir-excess pressure parameters. B: Results 
of a minimally adjusted (age and sex) logistic regression analysis of conventional central and 
peripheral artery hemodynamic parameters. C: Results of multivariate logistic regression 
analysis of reservoir-excess pressure parameters. D: Results of multivariate logistic 
regression analysis of conventional central and peripheral artery hemodynamic parameters. 
In C and D, age, sex, total and HDL cholesterol, current smoking, systolic blood pressure, 
pharmacological hypertensive treatment at baseline, and study centre were included in the 
model in addition to each reservoir-excess pressure parameter, and conventional central 
and peripheral artery hemodynamic parameters. INTPR, reservoir pressure integral; MAXPR, 
peak reservoir pressure; INTXSP, excess pressure integral; SRC, systolic rate constant; DRC, 
diastolic rate constant; CSBP, central systolic blood pressure; CDBP, central diastolic blood 






















    
    
    
    
    













central augmentation index adjusted for heart rate 75 beat per min; BSBP, brachial systolic 



































Table 1. Selected baseline characteristics, reservoir-excess pressure parameters, and conventional central and peripheral artery hemodynamic 
parameters of the study participants stratified by group. 
 
Parameter 1. Type 2 DM with CVD 
(n=306) 






p (1 v 2) p (1 v 3) p (2 v 3) 
Participants’ characteristics        
Age, yrs 70.4±7.8 67.7±8.4 67.2±8.9 <0.001 <0.001 <0.001 0.999 
Female, n (%) 94 (30.7) 142 (40.8) 83 (46.6) 0.001 - - - 
BMI, kg/m2 30.7 (30.2-31.2) 30.6 (30.1-31.1) 26.3 (25.6-27.0) <0.001 0.999 <0.001 <0.001 
Total CHOL, mmol/l 3.9 (3.8-4.0) 4.2 (4.1-4.3) 5.3 (5.2-5.4) <0.001 <0.001 <0.001 <0.001 
LDL CHOL, mmol/l 2.0 (1.9-2.1) 2.2 (2.1-2.3) 3.2 (3.1-3.3) <0.001 0.001 <0.001 <0.001 
HDL CHOL, mmol/l 1.2 (1.1-1.2) 1.3 (1.3-1.4) 1.6 (1.6-1.7) <0.001 <0.001 <0.001 <0.001 
Triglycerides, mmol/l 1.6 (1.5-1.6) 1.4 (1.3-1.5) 1.2 (1.1-1.3) <0.001 0.016 <0.001 0.002 
Fasting glucose, mmol/l 8.2 (7.9-8.5) 7.8 (7.5-8.1) 5.3 (5.1-5.6) <0.001 0.221 <0.001 <0.001 
HbA1c, mmol/mol 58.1 (56.6-60.0) 54.6 (53.3-55.9) 38.7 (37.4-40.0) <0.001 0.002 <0.001 <0.001 
Creatinine, µmol/l 87.3 (85.0-89.6) 79.3 (77.5-81.3) 79.2 (76.6-81.9) <0.001 <0.001 <0.001 0.999 
Brachial systolic BP, mmHg 134.9 (133.0-136.8) 135.8 (134.0-137.6) 133.2 (130.7-
135.7) 
0.262 - - - 
Brachial diastolic BP, mmHg 73.0 (72.0-73.9) 76.0 (75.1-76.9) 76.5 (75.2-77.8) <0.001 <0.001 <0.001 0.999 
Heart rate, bpm 61.8 (60.7-62.9) 63.1 (62.1-64.2) 57.9 (56.4-59.3) <0.001 0.273 <0.001 <0.001 
eGFR, ml/min/1.73m2 75.6 (73.4-77.9) 82.6 (80.6-84.6) 82.3 (79.5-85.1) <0.001 <0.001 0.001 0.999 
Current smoker, n (%) 31 (10.1) 28 (8.1) 15 (8.4) 0.627 - - - 
HT-Rx, n (%) 283 (92.5) 241 (69.3) 55 (30.9) <0.001 - - - 

































Glitazone, n (%) 18 (5.9) 19 (5.5) - 0.804 - - - 
Metformin, n (%) 196 (64.1) 253 (72.7) - 0.024 - - - 
Sulfonylureas, n (%) 84 (27.5) 97 (27.9) - 0.950 - - - 
DPP-4 inhibitors, n (%) 22 (7.2) 29 (8.3) - 0.614 - - - 
Insulin, n (%) 100 (32.7) 63 (18.1) - <0.001 - - - 
Incretin analogues, n (%) 16 (5.2) 19 (5.5) - 0.907 - - - 
  Conventional hemodynamic parameters 
Central systolic BP, mmHg 125.7 (123.8-127.7) 126.3 (124.4-128.1) 126.3 (123.7-
128.8) 
0.913 - - - 
Central diastolic BP, mmHg 74.2 (73.2-75.2) 77.5 (76.5-78.5) 78.0 (76.6-79.3) <0.001 <0.001 <0.001 0.999 
Central PP, mmHg 51.6 (50.1-53.0) 48.7 (47.4-50.1) 48.3 (46.4-50.2) 0.006 0.016 0.022 0.999 
Central AP, mmHg 16.6 (15.9-17.4) 15.4 (14.6-16.1) 16.8 (15.8-17.8) 0.025 0.064 0.999 0.076 
Central AIx@HR75, % 
 
24.7 (23.9-25.6) 24.6 (23.8-25.4) 25.7 (24.6-26.7) 0.259 - - - 
Brachial PP, mmHg 62.0 (60.6-63.5) 59.9 (58.5-61.3) 56.8 (54.8-58.7) <0.001 0.123 <0.001 0.027 
   
Data are shown as means±SD, means (95% confidence intervals), or numbers (%). p-values shown for between-group comparisons (e.g. 1 v 2) 
are those that are corrected by a Bonferroni post hoc test. BMI, body mass index; CHOL, cholesterol; LDL, low-density lipoprotein; HDL, high-
density lipoprotein; HbA1c, haemoglobin A1c; BP, blood pressure; eGFR, estimated glomerular filtration rate; HT-Rx, pharmacological 
hypertensive treatment at baseline; DPP-4, Dipeptidyl peptidase-4; INTPR, reservoir pressure integral; MAXPR, peak reservoir pressure; INTXSP, 
excess pressure integral; SRC, systolic rate constant; DRC, diastolic rate constant; BP, blood pressure; PP, pulse pressure; AP, augmented 























    
    
    
    
    













Table 2. Selected baseline characteristics, reservoir-excess pressure parameters, and 
conventional central and peripheral artery hemodynamic parameters of individuals with 
type 2 diabetes stratified by the incidence of cardiovascular event during the 3-year follow-
up period. 
 
Parameter No Event (n=559) Event (n=83) p 
Participants’ characteristics 
Age, yrs 69.0±8.2 69.2±8.4 0.898 
Female, n (%) 202 (36.1) 27 (32.5) 0.522 
BMI, kg/m2 30.4±5.1 30.9±5.4 0.391 
Total CHOL, mmol/l 4.1±1.0 4.0±0.9 0.625 
LDL CHOL, mmol/l 2.1±0.8 2.1±0.7 0.639 
HDL CHOL, mmol/l 1.3±0.4 1.2±0.4 0.256 
Triglycerides, mmol/l 
Fasting glucose, mmol/l 
HbA1c, mmol/mol 
1.4 (1.0-2.0) 1.4 (1.0-1.9) 0.843 
Fasting glucose, mmol/l 7.9 (6.6-9.4) 7.8 (6.7-9.5) 0.858 
HbA1c, mmol/mol 56.0 (48.0-64.0) 57.0 (51.0-70.0) 0.039 
Creatinine, µmol/l 83.0 (69.0-96.0) 81.5 (71.0-98.0) 0.838 
Brachial systolic BP, 
mmHg 
135.2±18.2 138.0±17.1 0.202 
Brachial diastolic BP, 
mmHg 
74.6±8.9 74.1±8.9 0.630 
Heart rate, bpm 62.0±10.3 64.6±11.2 0.032 
eGFR, ml/min/1.73m2 79.1±21.5 79.7±21.6 0.812 
History of CVD, n (%) 247 (44.2) 54 (65.1) <0.001 
Current smoker, n (%) 42 (7.5) 13 (15.7) 0.018 
HT-Rx, n (%) 446 (79.8) 71 (85.5) 0.216 
Statin, n (%) 429 (76.7) 67 (80.7) 0.329 
Glitazone, n (%) 31 (5.6) 6 (7.2) 0.494 
Metformin, n (%) 386 (69.1) 54 (65.1) 0.632 
Sulfonylureas, n (%) 160 (28.6) 16 (19.3) 0.088 
DPP-4 inhibitors, n (%) 47 (8.4) 3 (3.6) 0.136 
Insulin, n (%) 127 (22.7) 32 (38.6) 0.001 
Incretin analogues, n (%) 30 (5.4) 2 (2.4) 0.258 
Reservoir-excess pressure parameters 
INTPR, mmHg·s 87.8±16.7 82.4±15.7 0.006 
MAXPR, mmHg 106.6±14.4 106.2±15.2 0.847 






















    
    
    
    
    













SRC, 1/s 6.7 (5.7-7.8) 6.5 (5.4-7.8) 0.451 
DRC, 1/s 2.4 (1.9-2.9) 2.7 (2.2-3.2) <0.001 
Conventional hemodynamic parameters 
Central systolic BP, 
mmHg 
125.9±18.4 128.2±18.8 0.298 
Central diastolic BP, 
mmHg 
76.0±9.1 75.2±10.4 0.499 
Central PP, mmHg 50.0±14.6 53.0±13.6 0.078 




Central AIx@HR75, %  24.6±7.6 24.9±8.2 0.687 
Brachial systolic BP, 
mmHg 
135.2±18.2 138.0±17.1 0.202 
   Brachial PP, mmHg        60.7±14.8                 64.3±14.5        0.042 
 
Data are shown as means±SD, median (interquartile range), or numbers (%). BMI, body 
mass index; CHOL, cholesterol; LDL, low-density lipoprotein; HDL, high-density lipoprotein; 
HbA1c, haemoglobin A1c; BP, blood pressure; PP, pulse pressure; eGFR, estimated 
glomerular filtration rate; HT-Rx, pharmacological hypertensive treatment. BMI, body mass 
index; CHOL, cholesterol; HDL, high-density lipoprotein;HbA1c, haemoglobin A1c; BP, blood 
pressure; eGFR, estimated glomerular filtration rate; CVD, cardiovascular disease; HT-Rx, 
pharmacological hypertensive treatment at baseline; DPP-4, Dipeptidyl peptidase-4; INTPR, 
reservoir pressure integral; MAXPR, peak reservoir pressure; INTXSP, excess pressure 
integral; SRC, systolic rate constant; DRC, diastolic rate constant; BP, blood pressure; PP, 
pulse pressure; AP, augmented pressure; AIx@HR75, augmentation index adjusted for heart 
























    
    
    
    
    













Table 3. Multivariate logistic regression analysis of reservoir-excess pressure parameters, 
and conventional central and peripheral artery hemodynamic parameters for predicting 
cardiovascular events in individuals with type 2 diabetes. 
 
Parameter Odds Ratio 95% CI p 
Reservoir-excess pressure parameters 
INTPR, mmHg·s 0.489 0.280-0.853 0.012 
MAXPR, mmHg 0.909 0.586-1.410 0.669 
INTXSP, mmHg·s 1.121 0.744-1.688 0.586 
SRC, 1/s 1.164 0.918-1.475 0.210 
DRC, 1/s 1.488 1.134-1.952 0.004 
Conventional hemodynamic parameters 
Central systolic BP, mmHg 1.083 0.582-2.015 0.801 
Central diastolic BP, mmHg 0.783 0.554-1.108 0.168 
Central PP, mmHg 1.558 0.914-2.657 0.103 
Central AP, mmHg 0.989 0.623-1.569 0.962 
Central AIx@HR75, % 0.991 0.733-1.339 0.951 
Brachial systolic BP, mmHg 1.268 0.965-1.667 0.089 
Brachial PP, mmHg 1.721 0.931-3.180 0.083 
  
Age, sex, total and HDL cholesterols, current smoking, systolic blood pressure, 
pharmacological hypertensive treatment, study centre, body mass index, resting heart rate, 
haemoglobin A1c, previous history of cardiovascular disease, estimated glomerular filtration 
rate, duration of T2DM and insulin treatment at baseline were included in the model in 
addition to each reservoir-excess pressure parameter, and conventional central and 
peripheral artery hemodynamic parameters. 95% CI, 95% confidence interval; INTPR, 
reservoir pressure integral; MAXPR, peak reservoir pressure; INTXSP, excess pressure 
integral; SRC, systolic rate constant; DRC, diastolic rate constant; BP, blood pressure; PP, 
pulse pressure; AP, augmented pressure; AIx@HR75, augmentation index adjusted for heart 
rate 75 beat per min. 
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